Evaluate the Efficacy of the Axl inhibitor Bemcentinib in the 5xFAD mouse model of Alzheimer’s Disease
Guyin Chen, Gizem Ozturk, Sílvia Porta, Virginia M‐Y Lee · 2025
Read Evaluate the Efficacy of the Axl inhibitor Bemcentinib in the 5xFAD mouse model of Alzheimer’s Disease by Guyin Chen, Gizem Ozturk, Sílvia Porta, Virginia M‐Y Lee (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710453.txt.
Description
Guyin Chen and co-authors test a drug against Alzheimer's disease in mice in a 2025 study. The drug, bemcentinib, blocks Axl, a receptor found on microglia, the immune cells of the brain. Active microglia release signals that can harm neurons and may aid plaque build-up.
The test used 5xFAD mice, which form amyloid plaques and show overactive microglia like human disease. The team checked whether the drug blocked Axl activity in the brain. They also judged whether that block changed disease signs. A treatment aimed at microglia, not at plaques alone, would open a new route in Alzheimer's care. Mouse results here are an early step.
Catalog record
| CREATOR | Guyin Chen, Gizem Ozturk, Sílvia Porta, Virginia M‐Y Lee |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |